Carly Kenselaar

Stock Analyst at Citigroup

(3.19)

# 1,163

Out of 5,090 analysts

8

Total ratings

100%

Success rate

97.16%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	KRYS Krystal Biotech	Maintains: Neutral	$155 → $176	$234.13	-24.83%	2	Jul 10, 2025
	TVTX Travere Therapeutics	Maintains: Buy	$35 → $32	$35.00	-8.57%	6	Jun 11, 2025

Krystal Biotech

Jul 10, 2025

Maintains: Neutral

Price Target: $155 → $176

Current: $234.13

Upside: -24.83%

Travere Therapeutics

Jun 11, 2025

Maintains: Buy

Price Target: $35 → $32

Current: $35.00

Upside: -8.57%